Literature DB >> 32183603

Comparison of ultrastructural changes and the anticarcinogenic effects of thymol and carvacrol on ovarian cancer cells: which is more effective?

Hulya Elbe1, Gurkan Yigitturk1, Turker Cavusoglu2,3, Tuba Baygar4, Melike Ozgul Onal1, Feral Ozturk1.   

Abstract

Ovarian cancer is the seventh most common cancer worldwide in women. Many anticancer drugs are currently used clinically have been isolated from plant species or are based on such substances. Thymol (5-methyl-2-isopropylphenol) and carvacrol are oxygenated aromatic compounds from the monoterpene group. They are the main constituents of thyme essential oil and show antiproliferative, antioxidant, and antiseptic properties. The aim of this study is to compare the antiproliferative and apoptotic effects of thymol and carvacrol on SKOV-3 ovarian cancer cell line. The cancer cells were treated with different concentrations of thymol and carvacrol (100, 200, 400, 600 µM) at 24 h and 48 h durations. The cell viability was investigated by MTT assay and analysis of apoptosis with annexin V assay was determined. The study show that thymol and carvacrol significantly induced apoptosis in all groups as dose and time-dependent (p < .05). The data in the present study demonstrated that thymol and carvacrol have apoptotic and antiproliferative properties in a concentration-dependent manner toward ovarian cancer cells. SKOV-3 cancer cell line was much more sensitive to the toxic effect of thymol than carvacrol.

Entities:  

Keywords:  Apoptosis; antiproliferative; carvacrol; ovarian cancer; thymol; ultrastructure

Mesh:

Substances:

Year:  2020        PMID: 32183603     DOI: 10.1080/01913123.2020.1740366

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  7 in total

1.  Thymol has anticancer effects in U-87 human malignant glioblastoma cells.

Authors:  Farid Qoorchi Moheb Seraj; Niloofar Heravi-Faz; Arash Soltani; Seyed Sajad Ahmadi; Fatemeh Shahbeiki; Amir Talebpour; Amir R Afshari; Gordon A Ferns; Afsane Bahrami
Journal:  Mol Biol Rep       Date:  2022-08-23       Impact factor: 2.742

2.  Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation.

Authors:  Dalia Mahmoud Abdelmonem Elsherbini; Hailah M Almohaimeed; Mohamed El-Sherbiny; Zuhair M Mohammedsaleh; Nehal M Elsherbiny; Sami A Gabr; Hasnaa Ali Ebrahim
Journal:  Antioxidants (Basel)       Date:  2022-06-11

3.  Non-Volatile and Volatile Bioactives of Salvia officinalis L., Thymus serpyllum L. and Laurus nobilis L. Extracts with Potential Use in the Development of Functional Beverages.

Authors:  Ivanka Maleš; Verica Dragović-Uzelac; Igor Jerković; Zoran Zorić; Sandra Pedisić; Maja Repajić; Ivona Elez Garofulić; Ana Dobrinčić
Journal:  Antioxidants (Basel)       Date:  2022-06-10

Review 4.  A Narrative Review of the Antitumor Activity of Monoterpenes from Essential Oils: An Update.

Authors:  Thaíssa Q Machado; Anna C C da Fonseca; Allana B S Duarte; Bruno K Robbs; Damião P de Sousa
Journal:  Biomed Res Int       Date:  2022-05-24       Impact factor: 3.246

5.  Antitumor Effects of Carvacrol and Thymol: A Systematic Review.

Authors:  Laeza Alves Sampaio; Lícia Tairiny Santos Pina; Mairim Russo Serafini; Débora Dos Santos Tavares; Adriana Gibara Guimarães
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

6.  Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma.

Authors:  Xieling Yin; Hongjian Chen; Shi Chen; Suqing Zhang
Journal:  Dis Markers       Date:  2022-03-30       Impact factor: 3.434

7.  High anticancer efficacy of solid lipid nanoparticles containing Zataria multiflora essential oil against breast cancer and melanoma cell lines.

Authors:  Alireza Valizadeh; Ali Asghar Khaleghi; Ghazaal Roozitalab; Mahmoud Osanloo
Journal:  BMC Pharmacol Toxicol       Date:  2021-09-30       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.